Multiple high-risk cytogenetic aberrations confer a progressively negative impact on survivals of newly diagnosed myeloma patients

被引：0
|
作者：
Mao, Xuehan [1 ,2 ]
Xu, Yan [3 ]
Yan, Yuting [1 ,2 ]
Liu Jiahui [1 ,2 ]
Fan Huishou [1 ,2 ]
Sui Weiwei [1 ,2 ]
Zengjun, Lizengjun [1 ,2 ]
Deng, Shuhui [4 ,5 ]
Yi, Shuhua [1 ,2 ]
Wang, Tingyu [1 ,2 ]
Wang, Qi [6 ]
Liu, Hui-Min [1 ,2 ]
Qiu, Lugui [1 ,2 ]
An, Gang [1 ,2 ]
机构：
[1] Chinese Acad Med Sci & Peking Union, Inst Hematol, Tianjin, Peoples R China
[2] Chinese Acad Med Sci & Peking Union, Blood Dis Hosp, Tianjin, Peoples R China
[3] Chinese Acad Med Sci, Inst Hematol & Blood Dis, Tianjin, Peoples R China
[4] Chinese Acad Med Sci, Inst Hematol, Tianjin, Peoples R China
[5] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China
[6] Chinese Acad Med Sci & Peking Union Medi, Iymphoma & Myeloma, Blood Dis Hosp, Tianjin, Peoples R China
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
cytogenetic abnormality; myeloma; survival;
D O I：
10.1016/j.clml.2019.09.132
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FP-047
引用
收藏
页码：E83 / E83
页数：1
相关论文
共 50 条
  • [31] Characteristics and Risk Factors of Ultra-High-Risk Patients with Newly Diagnosed Multiple Myeloma
    Geng, Chuanying
    Yang, Guangzhong
    Zhou, Huixing
    Wang, Huijuan
    Li, Yanchen
    Leng, Yun
    Zhang, Zhiyao
    Jian, Yuan
    Chen, Wenming
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (04):
  • [32] Cellular Proliferation by Multiplex Immunohistochemistry Identifies High-Risk Multiple Myeloma in Newly Diagnosed, Treatment-Naive Patients
    Ely, Scott
    Forsberg, Peter
    Ouansafi, Ihsane
    Rossi, Adriana
    Modin, Alvin
    Pearse, Roger
    Pekle, Karen
    Perry, Arthur
    Coleman, Morton
    Jayabalan, David
    Di Liberto, Maurizio
    Chen-Kiang, Selina
    Niesvizky, Ruben
    Mark, Tomer M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (12): : 825 - 833
  • [33] Tandem autologous stem cell transplantation in high-risk patients with newly diagnosed multiple myeloma: Feasibility and preliminary results
    De La Rubia, Javier
    Jimenez, Maria
    Legarda Campo, Mario A.
    Rubio, Lucia
    Frances, Eva
    Jose Cejalvo, Maria
    Ribas, Paz
    Gomez, Elena
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E203 - E204
  • [34] Impact of autologous stem cell transplantation (ASCT) on progression free survival (PFS) in newly diagnosed multiple myeloma patients (NDMM) with high risk cytogenetic abnormalities
    Guman, Tomas
    Sykora, Jan
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2024, 125 (01): : 9 - 11
  • [35] An evaluation of c-myc aberrations in patients with newly diagnosed multiple myeloma (NDMM).
    Guzdar, Amy
    Costello, Caitlin
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [36] Quadruplet regimen for newly diagnosed multiple myeloma is effective in the standard-risk subgroup but not in the high-risk subgroup
    Ding, Jianghua
    Gong, Shengping
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [37] High risk cytogenetic abnormalities in patients with multiple myeloma
    Eugenia Legues, Maria
    Morales, Paulina
    Valenzuela, Mercedes
    Encina, Andrea
    Jose Marti, Maria
    Bascunan, Claudia
    Cornejo, Paulina
    Pena, Camila
    Soledad Undurraga, Maria
    REVISTA MEDICA DE CHILE, 2019, 147 (01) : 61 - 64
  • [38] Cell Free MYC DNA Copy Number Identifies High-Risk Smouldering Myeloma and Newly Diagnosed Multiple Myeloma
    Wong, Daniel
    Reynold, John
    Wellard, Cameron
    Bingham, Nicholas
    Zhao, Jessie
    Ramachandran, Malarmathy
    Quach, Hang
    Gibbs, Simon
    Khong, Tiffany T.
    Mithraprabhu, Sridurga
    Spencer, Andrew
    BLOOD, 2023, 142
  • [39] High Risk Cytogenetic Abnormalities Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients Received Autologous Hematopoietic Cell Transplantation
    Geng, Chuanying
    Lu, Jing
    Li, Xiaozhe
    Li, Qiang
    Li, Na
    Tian, Weiwei
    Zhao, Jie
    Yang, Guangzhong
    Ma, Yanping
    Qin, Xiaoqi
    Jia, Jing
    Zhou, Huixing
    Hi, Lintao
    Wang, Chenchen
    Sun, Ying
    Liu, Xiantao
    Jian, Yuan
    Wang, Qingming
    Wan, Haixiang
    Zhang, Jinqiao
    Liu, Han
    Geng, Hui
    Ma, Xiaojing
    Liang, Yunxia
    Hu, Rui
    Gao, Da
    Han, Donghai
    Liu, Haisheng
    Ma, Guangyu
    Zhang, Zhihua
    Wang, Wei
    Minxia, Shi
    Nie, Bo
    Hong, Zhang
    Li, Jie
    Jie, Guitao
    Fan, Meiying
    Song, Qinglin
    Li, Wenyong
    Xi, Zhenfan
    Gao, Guorong
    Liu, Jie
    Li, Zhihua
    Xue, Hua
    Guo, Huimei
    Li, Jie
    Gao, Xiaohan
    Su, Guo-Hong
    Shen, Jie
    Jin, Aron
    BLOOD, 2024, 144 : 6925 - 6926
  • [40] Cytogenetic and clinical risk factors for assessment of ultra high-risk multiple myeloma
    Zhuang, Junling
    Da, Yi
    Li, Hui
    Han, Bing
    Wan, Xia
    Zhu, Tienan
    Chen, Miao
    Duan, Minghui
    Xu, Ying
    Zhao, Yongqiang
    Shen, Ti
    Wu, Yongji
    Zhou, Daobin
    LEUKEMIA RESEARCH, 2014, 38 (02) : 188 - 193
12345